Maxeville

Researchers are evaluating whether the EMOCARE emotional monitoring software provides consistent results compared to standard questionnaires used to assess emotional states in patients with mild to moderately severe depressive episodes. This study aims to understand how well EMOCARE matches tools like PHQ-9, MADRS, GAD-7, BDI-II, and EQ-5D-5L, and to learn about any medical issues participants may experience when using this passive monitoring software. The study focuses on outpatients with major depressive disorder who use digital devices regularly. Participants will install the EMOCARE software on a smartphone, computer, or similar device and can activate or deactivate it during a six-week follow-up period. They will attend two scheduled visits at the centerone at the start and one six weeks laterto complete questionnaires and be interviewed by a doctor. Additionally, participants will complete questionnaires independently at home two and four weeks after the first appointment. A phone call from the doctor will take place three weeks after the initial visit to check on how participants are feeling. Participants will also keep a diary of symptoms, medical consultations, and any medication changes. Throughout the study, researchers will collect and compare scores from EMOCARE and various questionnaires at multiple time points, including baseline, two, four, and six weeks. They will monitor the acceptability of the device, adverse events, and changes in depression severity. The main outcomes measured are changes in EMOCARE scores and PHQ-9 scores from baseline to six weeks. The total participation duration is six weeks, with regular monitoring and assessments to understand emotional states and device use.

Researchers are investigating the complex relationships between trauma, substance use, migration experiences, and mental health perceptions among vulnerable young adults living in Transitional Housing in France. The study, called ATICC, uses a mixed-methods approach to understand risk factors, barriers to healthcare access, and the impact of group interventions on psychological well-being and attitudes toward mental health care. This research aims to develop culturally adapted prevention and support programs for this population. The study includes three parts a cross-sectional survey to identify risk factors using standardized questionnaires qualitative interviews with a subset of participants who use substances to explore their personal experiences and a longitudinal intervention involving focus groups called Well-Being Coffee Group. These groups meet in person or via videoconference, led by a psychologist, to discuss topics such as identity, substance use, migration, and mental health. Participants complete evaluations before and after the intervention to assess changes. During the study, participants will be assessed using questionnaires and interviews to measure attitudes toward mental health care, anxiety, depression, and substance use over six months. Data will be analyzed with advanced statistical methods to understand the interventions effects. The study includes quality assurance processes to ensure ethical compliance and data accuracy. Participant confidentiality is maintained through anonymized data and GDPR-compliant procedures. The total study duration includes repeated assessments and follow-up to track psychological and behavioral changes.